Results 61 to 70 of about 21,505 (224)
BJS (British Journal of Surgery), EarlyView., 2020 This study investigated postoperative complications after surgery for medullary thyroid carcinoma (MTC) in Europe. Hypoparathyroidism, recurrent laryngeal nerve palsy and bleeding requiring reoperation occurred in 170 (26·2 per cent), 62 (13·7 per cent) and 17 (2·6 per cent) patients respectively.
D.‐J. van Beek +18 more
wiley +1 more source
, 2021 Adenocarcinomas and noninvasive intraepithelial neoplasms (either polypoid or flat) are the most common gallbladder tumors; however, neuroendocrine neoplasms (NENs) can also occur. The majority of NENs are represented by neuroendocrine carcinomas (NECs),
Lauwers Gregory Y. +3 more
core +1 more source
Gastric mixed neuroendocrine non-neuroendocrine neoplasms
Frontiers in OncologyThe uncommon tumour known as gastric mixed neuroendocrine-non-neuroendocrine neoplasms (G-MiNENs) is made up of parts of neuroendocrine carcinoma and adenocarcinoma. The biological and clinical features are different from those of gastric adenocarcinoma.
Li Liu +6 more
openaire +3 more sources
, 2021 Mixed neuroendocrine/non-neuroendocrine neoplasms (MiNEN) are rare mixed epithelial neoplasms in which a neuroendocrine component is combined with a non-neuroendocrine component.
Sciammarella, Concetta +29 more
core +1 more source
World Journal of Surgical Oncology, 2022 Background Neuroendocrine carcinoma (NEC) and mixed neuroendocrine-non-neuroendocrine neoplasm (MiNEN) are extremely rare subtypes of gastric cancer. MiNEN is a mix of carcinomatous components and neuroendocrine neoplasm in the same lesion. NEC and MiNEN
Kenichi Iwasaki +9 more
doaj +1 more source
Gastroenterology Research, 2020 Neuroendocrine neoplasms of the gallbladder are rare, comprising 0.5% of all neuroendocrine cancers and about 2% of gallbladder cancers. These neoplasms can also be found along with other malignant neoplasms of epithelial origin, mostly adenocarcinomas.
Alawad, Mouyed +3 more
openaire +3 more sources
KDM7A and KDM1A inhibition suppresses tumour promoting pathways in prostate cancer
Molecular Oncology, EarlyView.Treatment resistance is a major challenge for patients with advanced prostate cancer. This study examined an alternative approach to target the major prostate cancer‐promoting pathway by targeting epigenetic factors, whose levels are higher in tumours.
Jennie N Jeyapalan +16 more
wiley +1 more source
Gallbladder Mixed Neuroendocrine-Non-Neuroendocrine Neoplasms: A Case Report
International Journal of Innovative Research in Medical Science, 2020 The gallbladder Mixed neuroendocrine-non-neuroendocrine neoplasms (MiNEN) are extremely rare. The association of at least two components including one neuroendocrine tumor, and a non-neuroendocrine one defines MiNEN. We are reporting a case of 50-year-old woman referred to our department for management of a gallbladder tumor suspected on imaging.
EL Mehdi Aboulfeth +5 more
openaire +2 more sources
Pancreatic neuroendocrine neoplasms: Clinicopathological features and pathological staging [PDF]
, 2021 . The nomenclature and classification of pancreatic neuroendocrine neoplasms has evolved in the last 15 years based on the advances in knowledge of the genomics, clinical behaviour and response to therapies. The current 2019 World Health Organization
Lam, Alfred King-yin, Ishida, Hirotaka
core +1 more source
Advanced Science, EarlyView.Pancreatic neuroendocrine tumors frequently silence MEN1 through epigenetic mechanisms. Here, SIRT7 recruits DNMT1 to the MEN1 promoter, drives hypermethylation, and enhances DNA repair. Inhibiting SIRT7 restores MEN1, reduces MRN complex abundance, impairs double‐strand break repair, and sensitizes PanNET models to radiation, supporting SIRT7 as a ...
Jianyun Jiang +11 more
wiley +1 more source